Europe Sequencing Reagents Market Size, Share & Trends Analysis Report By Type (Sequencing Kits, Library Kits, Control Kits, Template Kits, and Other Type), By Technology, By Application, By End Use, By Country and Growth Forecast, 2024 - 2031
The Europe Sequencing Reagents Market would witness market growth of 17.0% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Sequencing Reagents Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,320.9 million by 2031. The UK market is exhibiting a CAGR of 16% during (2024 - 2031). Additionally, The France market would experience a CAGR of 18% during (2024 - 2031).
The sequencing reagents market has emerged as a critical component of the rapidly advancing field of genomics, pivotal in enabling cutting-edge research, clinical diagnostics, and therapeutic innovations. These reagents are the foundation of genomic sequencing workflows, facilitating processes such as DNA and RNA extraction, library preparation, amplification, and sequencing. With the focus on understanding the genetic underpinnings of diseases and biological systems, the demand for high-quality sequencing reagents continues to grow exponentially.
Additionally, the evolution of sequencing technologies has been a driving force behind the expanding market for sequencing reagents. From the early days of Sanger sequencing to the widespread adoption of next-generation sequencing (NGS) and third-generation sequencing technologies, advancements in accuracy, speed, and cost-effectiveness have transformed the genomics landscape.
The sequencing reagents market in Europe is characterized by its diverse applications and strong government support across various nations. Pharmaceutical and biotechnology companies across Europe are major contributors to the demand for sequencing reagents, as they integrate genomic data into drug discovery and development processes. Companies like AstraZeneca, Novartis, and Roche utilize sequencing to identify biomarkers, validate drug targets, and conduct pharmacogenomic studies. Government programs like the European Innovative Medicines Initiative (IMI) encourage collaboration between the public and private sectors, fostering the use of sequencing technologies in pharmaceutical R&D.
Based on Type, the market is segmented into Sequencing Kits, Library Kits, Control Kits, Template Kits, and Other Type. Based on Technology, the market is segmented into Next-Generation Sequencing, Third Generation Sequencing, and Sanger Sequencing. Based on Application, the market is segmented into Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Consumer Genomics, and Other Application. Based on End Use, the market is segmented into Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
- Illumina, Inc.
By Type
- Sequencing Kits
- Library Kits
- Control Kits
- Template Kits
- Other Type
- Next-Generation Sequencing
- Third Generation Sequencing
- Sanger Sequencing
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Consumer Genomics
- Other Application
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other End Use
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Sequencing Reagents Market, by Type
- 1.4.2 Europe Sequencing Reagents Market, by Technology
- 1.4.3 Europe Sequencing Reagents Market, by Application
- 1.4.4 Europe Sequencing Reagents Market, by End Use
- 1.4.5 Europe Sequencing Reagents Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, Feb – 2024, Apr) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. Europe Sequencing Reagents Market by Type
- 5.1 Europe Sequencing Kits Market by Country
- 5.2 Europe Library Kits Market by Country
- 5.3 Europe Control Kits Market by Country
- 5.4 Europe Template Kits Market by Country
- 5.5 Europe Other Type Market by Country
- Chapter 6. Europe Sequencing Reagents Market by Technology
- 6.1 Europe Next-Generation Sequencing Market by Country
- 6.2 Europe Third Generation Sequencing Market by Country
- 6.3 Europe Sanger Sequencing Market by Country
- Chapter 7. Europe Sequencing Reagents Market by Application
- 7.1 Europe Oncology Market by Country
- 7.2 Europe Reproductive Health Market by Country
- 7.3 Europe Clinical Investigation Market by Country
- 7.4 Europe Agrigenomics & Forensics Market by Country
- 7.5 Europe Consumer Genomics Market by Country
- 7.6 Europe Other Application Market by Country
- Chapter 8. Europe Sequencing Reagents Market by End Use
- 8.1 Europe Academic Research Market by Country
- 8.2 Europe Clinical Research Market by Country
- 8.3 Europe Hospitals & Clinics Market by Country
- 8.4 Europe Pharmaceutical & Biotechnology Companies Market by Country
- 8.5 Europe Other End Use Market by Country
- Chapter 9. Europe Sequencing Reagents Market by Country
- 9.1 Germany Sequencing Reagents Market
- 9.1.1 Germany Sequencing Reagents Market by Type
- 9.1.2 Germany Sequencing Reagents Market by Technology
- 9.1.3 Germany Sequencing Reagents Market by Application
- 9.1.4 Germany Sequencing Reagents Market by End Use
- 9.2 UK Sequencing Reagents Market
- 9.2.1 UK Sequencing Reagents Market by Type
- 9.2.2 UK Sequencing Reagents Market by Technology
- 9.2.3 UK Sequencing Reagents Market by Application
- 9.2.4 UK Sequencing Reagents Market by End Use
- 9.3 France Sequencing Reagents Market
- 9.3.1 France Sequencing Reagents Market by Type
- 9.3.2 France Sequencing Reagents Market by Technology
- 9.3.3 France Sequencing Reagents Market by Application
- 9.3.4 France Sequencing Reagents Market by End Use
- 9.4 Russia Sequencing Reagents Market
- 9.4.1 Russia Sequencing Reagents Market by Type
- 9.4.2 Russia Sequencing Reagents Market by Technology
- 9.4.3 Russia Sequencing Reagents Market by Application
- 9.4.4 Russia Sequencing Reagents Market by End Use
- 9.5 Spain Sequencing Reagents Market
- 9.5.1 Spain Sequencing Reagents Market by Type
- 9.5.2 Spain Sequencing Reagents Market by Technology
- 9.5.3 Spain Sequencing Reagents Market by Application
- 9.5.4 Spain Sequencing Reagents Market by End Use
- 9.6 Italy Sequencing Reagents Market
- 9.6.1 Italy Sequencing Reagents Market by Type
- 9.6.2 Italy Sequencing Reagents Market by Technology
- 9.6.3 Italy Sequencing Reagents Market by Application
- 9.6.4 Italy Sequencing Reagents Market by End Use
- 9.7 Rest of Europe Sequencing Reagents Market
- 9.7.1 Rest of Europe Sequencing Reagents Market by Type
- 9.7.2 Rest of Europe Sequencing Reagents Market by Technology
- 9.7.3 Rest of Europe Sequencing Reagents Market by Application
- 9.7.4 Rest of Europe Sequencing Reagents Market by End Use
- Chapter 10. Company Profiles
- 10.1 Agilent Technologies, Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Acquisition and Mergers:
- 10.1.6 SWOT Analysis
- 10.2 F. Hoffmann-La Roche Ltd.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Partnerships, Collaborations, and Agreements:
- 10.2.5.2 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
- 10.3 Danaher Corporation (Beckman Coulter, Inc.)
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 SWOT Analysis
- 10.4 Abbott Laboratories
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Partnerships, Collaborations, and Agreements:
- 10.4.6 SWOT Analysis
- 10.5 Bio-Rad laboratories, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Partnerships, Collaborations, and Agreements:
- 10.5.5.2 Product Launches and Product Expansions:
- 10.5.6 SWOT Analysis
- 10.6 Quest Diagnostics Incorporated
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental Analysis
- 10.6.4 SWOT Analysis
- 10.7 Revvity, Inc.
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Partnerships, Collaborations, and Agreements:
- 10.7.6 SWOT Analysis
- 10.8 Eurofins Scientific SE
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Recent strategies and developments:
- 10.8.4.1 Partnerships, Collaborations, and Agreements:
- 10.8.5 SWOT Analysis
- 10.9 Hologic, Inc.
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental and Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Acquisition and Mergers:
- 10.9.6 SWOT Analysis
- 10.10. Illumina, Inc.
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Segment and Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
- 10.10.5.1 Product Launches and Product Expansions:3
- 10.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook